C4 Therapeutics, Inc. (CCCC)
3.10
+0.15
(+5.08%)
USD |
NASDAQ |
Nov 06, 16:00
3.09
-0.01
(-0.32%)
After-Hours: 20:00
C4 Therapeutics EPS Diluted (Quarterly) : -0.1605 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.1605 |
| June 30, 2026 | -0.1808 |
| March 31, 2026 | -0.1993 |
| December 31, 2025 | -0.1754 |
| September 30, 2025 | -0.4433 |
| June 30, 2025 | -0.3664 |
| March 31, 2025 | -0.3716 |
| December 31, 2024 | -0.4897 |
| September 30, 2024 | -0.3543 |
| June 30, 2024 | -0.2575 |
| March 31, 2024 | -0.4144 |
| December 31, 2023 | -0.6786 |
| September 30, 2023 | -0.5494 |
| June 30, 2023 | -0.7322 |
| March 31, 2023 | -0.7093 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.7594 |
| September 30, 2022 | -0.6532 |
| June 30, 2022 | -0.5614 |
| March 31, 2022 | -0.6488 |
| December 31, 2021 | -0.3216 |
| September 30, 2021 | -0.509 |
| June 30, 2021 | -0.5149 |
| March 31, 2021 | -0.4867 |
| December 31, 2020 | -0.2655 |
| September 30, 2020 | -0.6286 |
| June 30, 2020 | -0.3182 |
| March 31, 2020 | -0.3257 |
| December 31, 2019 | -0.2782 |
| September 30, 2019 | -0.2857 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -0.9094 |
| Kymera Therapeutics, Inc. | -1.319 |
| NKGen Biotech, Inc. | -- |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.84M |
| Revenue (Quarterly) | 8.468M |
| Total Expenses (Quarterly) | 30.31M |
| Enterprise Value | 256.91M |
| Gross Profit Margin (Quarterly) | 78.90% |
| Profit Margin (Quarterly) | -257.9% |
| Earnings Yield | -23.10% |
| Normalized Earnings Yield | -23.10 |